Select for export Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.09.133 PubMed 39343309 Copy citation Copy BibTeX Journal of Affective Disorders 2024-09-26 Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen OpenAlex Published psilocybin DepressionChronic PainClinical Trial Clinical Trial More
Select for export Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-4492873/v1 Copy citation Copy BibTeX Research Square 2024-09-25 Allohverdi S, Soltanzadeh M, Schmidt A, Charlton C, Hauke D, Karvelis P Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2024.102799 PubMed 39764567 Copy citation Copy BibTeX EClinicalMedicine 2024-09-22 David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241278873 PubMed 39302087 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-09-19 Abigail E. Calder, Benjamin Rausch, Matthias E. Liechti, Friederike Holze, Gregor Hasler OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/head.14837 PubMed 39301810 Copy citation Copy BibTeX Headache The Journal of Head and Face Pain 2024-09-19 James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema OpenAlex Published psilocybin Chronic PainHeadache / MigrainePharmacology Clinical Trial More
Select for export Less is more? A review of psilocybin microdosing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241278769 PubMed 39282928 Copy citation Copy BibTeX Unknown journal 2024-09-15 Savides IA, Outhoff K. Europe PMC Published psilocybin MicrodosingPersonality ChangeSystematic Review Systematic Review More
Select for export Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/14651858.cd015383.pub2 PubMed 39260823 Copy citation Copy BibTeX Unknown journal 2024-09-11 Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.09.09.24313316 Copy citation Copy BibTeX medRxiv 2024-09-10 Nikolic M, Mediano P, Froese T, Reydellet D, Palenicek T. medRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingReceptor PharmacologyDefault Mode Network Other More
Select for export G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/rapm-2024-esra.582 Copy citation Copy BibTeX Unknown journal 2024-08-31 Amany E. Ayad OpenAlex Published psilocybin DepressionPTSDAddiction Randomized Controlled Trial More
Select for export Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2024.65789.rfs2023 Copy citation Copy BibTeX Psychedelic Medicine 2024-08-31 Albert Garcia-Romeu OpenAlex Published psilocybin Receptor PharmacologyConsciousnessWellbeing Other More
Select for export Refractory CRPS pain treated with psilocybin: A case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/ccr3.9421 PubMed 39281029 Copy citation Copy BibTeX Clinical Case Reports 2024-08-31 David S. Jevotovsky, Harman Chopra, Court Wing, Carlton J. Spotswood, Joel Castellanos OpenAlex Published psilocybin Chronic PainPharmacologyMechanism of Action Case Report More
Select for export Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided Imagery Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31579/2834-8761/056 Copy citation Copy BibTeX Clinical Endocrinology and Metabolism 2024-08-29 Jerry B. Brown *, Julie M. Brown OpenAlex Published psilocybin End-of-Life DistressChronic PainEmotional Processing Other More
Select for export Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/ccr3.9305 PubMed 39219779 Copy citation Copy BibTeX Clinical Case Reports 2024-08-29 Federico Seragnoli, Martignoni Geo, Martignoni Entela, Silke Bachmann, Elisa Rabitti, Silvio Cavuto OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Case Report More
Select for export The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.08.26.24311611 Copy citation Copy BibTeX medRxiv 2024-08-25 Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M medRxiv PREPRINT (not peer reviewed) psilocybinpsilocin AnxietyBrain ImagingConsciousness Clinical Trial More
Select for export Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-4947184/v1 Copy citation Copy BibTeX Research Square 2024-08-22 Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM Europe PMC PREPRINT (not peer reviewed) psilocybinpsilocin AddictionPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/bmj-2023-078607 PubMed 39168500 Copy citation Copy BibTeX Unknown journal 2024-08-20 Hsu TW, Tsai CK, Kao YC, Thompson T, Carvalho AF, Yang FC Europe PMC Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD) Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-08-14 Clairvoyant Therapeutics ClinicalTrials.gov CLINICAL TRIAL psilocybin AddictionClinical TrialSafety Clinical Trial More
Select for export Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-08-06 Brugmann University Hospital ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s44220-024-00298-y Copy citation Copy BibTeX Nature Mental Health 2024-08-04 Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, Niamh Bourke, Robin Carhart-Harris, Morten L. Kringelbach OpenAlex Published psilocybin DepressionAnxietyBrain Imaging Randomized Controlled Trial More
Select for export From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241265762 PubMed 39075756 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-07-28 Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica J. Barratt, Adam Winstock OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
